Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20024401HPVENSG00000131759.18protein_codingRARANoNo5914A8MUP8
P10276
Q6I9R7
TVIS20021335HPVENSG00000131759.18protein_codingRARANoNo5914A8MUP8
P10276
Q6I9R7
TVIS44049649HTLV-1ENSG00000131759.18protein_codingRARANoNo5914A8MUP8
P10276
Q6I9R7
TVIS44049650HTLV-1ENSG00000131759.18protein_codingRARANoNo5914A8MUP8
P10276
Q6I9R7
TCGA Plot Options
Drug Information
GeneRARA
DrugBank IDDB04942
Drug NameTamibarotene
Target IDBE0000663
UniProt IDP10276
Regulation Typeagonist
PubMed IDs17925887; 15843826; 11752352; 17611697; 15563242
CitationsMiwako I, Kagechika H: Tamibarotene. Drugs Today (Barc). 2007 Aug;43(8):563-8.@@Sanda T, Kuwano T, Nakao S, Iida S, Ishida T, Komatsu H, Shudo K, Kuwano M, Ono M, Ueda R: Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis. Leukemia. 2005 Jun;19(6):901-9.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Jimi S, Mashima K, Matsumoto T, Hara S, Suzumiya J, Tamura K: RARalpha is a regulatory factor for Am-80-induced cell growth inhibition of hematologic malignant cells. Int J Oncol. 2007 Aug;31(2):397-404.@@Authors unspecified: Tamibarotene: AM 80, retinobenzoic acid, Tamibaro. Drugs R D. 2004;5(6):359-62.
GroupsInvestigational
Direct ClassificationTetralins
SMILESCC1(C)CCC(C)(C)C2=C1C=CC(NC(=O)C1=CC=C(C=C1)C(O)=O)=C2
Pathways
PharmGKBPA164743464
ChEMBLCHEMBL25202